SA PRO
Free Account
PTHSPTHS
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
1 analyst·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 119% higher.

Bear Case
$50.00
+98%
Consensus
$55.40
+119%
Bull Case
$60.00
+137%
Price Range1 analyst
Low
Consensus
High
$50.00
$60.00
Current Target
Current Price
$25.30
Upside to Target
$30.10

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 26, 2026Oppenheimer
Pelthos Therapeutics price target raised to $60 from $57 at Oppenheimer
Target:$60.00
+142.4%from $24.75
Dec 3, 2025Lake Street
Pelthos Therapeutics initiated with a Buy at Lake Street
Target:$50.00
+82.6%from $27.38
Dec 3, 2025H.C. Wainwright
Pelthos Therapeutics initiated with a Buy at H.C. Wainwright
Target:$60.00
+138.7%from $25.14
Nov 25, 2025Roth Capital
Pelthos Therapeutics initiated with a Buy at Roth Capital
Target:$57.00
+107.0%from $27.53
Sep 2, 2025UBS
Pelthos Therapeutics initiated with an Outperform at Oppenheimer
Target:$50.00
+122.6%from $22.46

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance